Anti-Angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

This study has been completed.

Study NCT00076011 Information provided by Pfizer

First Received: January 12, 2004 Last Updated: August 14, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

No publications provided by Pfizer

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):